There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on DENTSPLY SIRONA (XRAY – Research Report), Envista Holdings (NVST – Research Report) and TELA Bio (TELA – Research Report) with bullish sentiments.
DENTSPLY SIRONA (XRAY)
In a report released today, Erin Wright from Morgan Stanley maintained a Buy rating on DENTSPLY SIRONA, with a price target of $44.00. The company’s shares closed last Wednesday at $36.27, close to its 52-week low of $33.78.
According to TipRanks.com, Wright is a 5-star analyst with an average return of
Currently, the analyst consensus on DENTSPLY SIRONA is a Moderate Buy with an average price target of $44.09.
Envista Holdings (NVST)
Morgan Stanley analyst Drew Ranieri maintained a Buy rating on Envista Holdings today and set a price target of $53.00. The company’s shares closed last Wednesday at $40.33.
According to TipRanks.com, Ranieri is a 1-star analyst with an average return of
Envista Holdings has an analyst consensus of Moderate Buy, with a price target consensus of $51.00.
TELA Bio (TELA)
JMP Securities analyst David Turkaly reiterated a Buy rating on TELA Bio today and set a price target of $22.00. The company’s shares closed last Wednesday at $8.01.
According to TipRanks.com, Turkaly is a 3-star analyst with an average return of
TELA Bio has an analyst consensus of Moderate Buy, with a price target consensus of $19.50.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on XRAY:
- Baker Hughes Plunges on Sour Earnings Report, but There’s Hope
- Tigress Financial Reiterates a Buy Rating on Cisco Systems (CSCO)
- Analysts Are Bullish on These Healthcare Stocks: Viking Therapeutics (VKTX), Hookipa Pharma (HOOK)
- Sonoco Declares Regular Quarterly Common Stock Dividend
- OVBC ANNOUNCES CASH DIVIDEND